The improved prognosis of <i>FLT3</i>-internal tandem duplication but not tyrosine kinase domain mutations in acute myeloid leukemia in the era of targeted therapy: a realworld study using large-scale electronic health record data
Authors
Matthew Schwede (ORCID: https://orcid.org/0000-0002-0778-9230)
Jonathan H. Chen (ORCID: https://orcid.org/0000-0002-4387-8740)
Eran Bendavid (ORCID: https://orcid.org/0000-0002-8364-4711)
Tian Yi Zhang (ORCID: https://orcid.org/0000-0002-6274-0763)
The improved prognosis of FLT3-internal tandem duplication but not tyrosine kinase domain mutations in acute myeloid leukemia in the era of targeted therapy: a realworld study using large-scale electronic health record data
Matthew Schwede, Jonathan H. Chen, Eran Bendavid, Tian Yi Zhang et al.
Journal
Haematologica
Topics
Acute Myeloid Leukemia Research
article
The improved prognosis of FLT3-internal tandem duplication but not tyrosine kinase domain mutations in acute myeloid leukemia in the era of targeted therapy: a realworld study using large-scale electronic health record data
Matthew Schwede, Jonathan H. Chen, Eran Bendavid, Tian Yi Zhang, Gladys Rodriguez, Ravindra Majeti, Douglas Wood, Gabriel N. Mannis, Vanessa E. Kennedy, Solomon Henry
article en
Abstract
No abstract available for this paper.
Publication Tag
HaematologicaVol. 110(7)
Institutions
Northwestern University (US), Cancer Institute (WIA) (IN), Institute for Stem Cell Biology and Regenerative Medicine (IN), Swedish Medical Center (US), Swedish Medical Center (US), Stanford Health Care (US), Stanford Medicine (US), Stanford University (US)